Mosaic ImmunoEngineering, Inc.
CPMV
$0.65
-$0.1057-13.99%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -8.79% | -31.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.42% | -32.05% | |||
| Operating Income | 19.42% | 32.05% | |||
| Income Before Tax | 19.34% | 36.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.05% | 36.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.05% | 36.43% | |||
| EBIT | 19.42% | 32.05% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 18.22% | 36.45% | |||
| Normalized Basic EPS | 19.25% | 36.61% | |||
| EPS Diluted | 29.67% | 26.11% | |||
| Normalized Diluted EPS | 19.25% | 36.61% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||